Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J B Aarts

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Netherlands Journal of Medicine|August 25, 2006
Mirizzi's syndromeM J B Aarts, L G J B Engels
Oncoimmunology|November 16, 2020
Immunotherapy as sensitizer for local radiotherapyBen G L Vanneste, Evert J Van Limbergen, Ludwig Dubois, et al.
ESMO Open|July 12, 2024
Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular eventsA T Meuleman, E L D Volders, S Lubberts, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2013
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancerB E P J Vriens, M J B Aarts, B de Vries, et al.
Clinical Epigenetics|May 5, 2021
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markersS C Joosten, S N O Odeh, A Koch, et al.
Breast Cancer Research and Treatment|July 5, 2017
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancerB E P J Vriens, I J H Vriens, M J B Aarts, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2021
Survival of stage IV melanoma in Belgium and the NetherlandsK P M Suijkerbuijk, J B A G Haanen, M J Boers-Sonderen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 20, 2023
Health-state utilities in long-term advanced melanoma survivors comparable with the general populationM D Egeler, L V van de Poll-Franse, R Tissier, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controlsA H Boekhout, A Rogiers, K Jozwiak, et al.
ESMO Open|December 2, 2021
Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugsM G Franken, B Leeneman, M J B Aarts, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Netherlands Journal of Medicine|August 25, 2006
Mirizzi's syndromeM J B Aarts, L G J B Engels
Oncoimmunology|November 16, 2020
Immunotherapy as sensitizer for local radiotherapyBen G L Vanneste, Evert J Van Limbergen, Ludwig Dubois, et al.
ESMO Open|July 12, 2024
Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular eventsA T Meuleman, E L D Volders, S Lubberts, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2013
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancerB E P J Vriens, M J B Aarts, B de Vries, et al.
Clinical Epigenetics|May 5, 2021
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markersS C Joosten, S N O Odeh, A Koch, et al.
Breast Cancer Research and Treatment|July 5, 2017
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancerB E P J Vriens, I J H Vriens, M J B Aarts, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2021
Survival of stage IV melanoma in Belgium and the NetherlandsK P M Suijkerbuijk, J B A G Haanen, M J Boers-Sonderen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 20, 2023
Health-state utilities in long-term advanced melanoma survivors comparable with the general populationM D Egeler, L V van de Poll-Franse, R Tissier, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controlsA H Boekhout, A Rogiers, K Jozwiak, et al.
ESMO Open|December 2, 2021
Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugsM G Franken, B Leeneman, M J B Aarts, et al.
Pageof 2